These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15853912)

  • 41. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.
    Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K
    Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
    Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI; Kim EK; Park SY; Lee SK; Hong YK; Kim TG
    Cancer Lett; 2007 Dec; 258(2):189-98. PubMed ID: 17931768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
    Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
    Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.
    Perreau M; Mennechet F; Serratrice N; Glasgow JN; Curiel DT; Wodrich H; Kremer EJ
    J Virol; 2007 Apr; 81(7):3272-84. PubMed ID: 17229706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative immunobiology of thymic DC mRNA in autoimmune-prone mice.
    Okada T; Inaba M; Naiki M; Lian ZX; Gershwin ME; Ikehara S
    J Autoimmun; 2007 Feb; 28(1):41-5. PubMed ID: 17140766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system.
    Korokhov N; Noureddini SC; Curiel DT; Santegoets SJ; Scheper RJ; de Gruijl TD
    Mol Pharm; 2005; 2(3):218-23. PubMed ID: 15934782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.
    Nabekura T; Otsu M; Nagasawa T; Nakauchi H; Onodera M
    Mol Ther; 2006 Feb; 13(2):301-9. PubMed ID: 16311073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.
    Yang JY; Cao DY; Liu WC; Zhang HM; Teng ZH; Ren J
    Cell Immunol; 2006 Mar; 240(1):14-21. PubMed ID: 16875681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
    Ishida A; Tanaka H; Hiura T; Miura S; Watanabe S; Matsuyama K; Kuriyama H; Tanaka J; Kagamu H; Gejyo F; Yoshizawa H
    Scand J Immunol; 2007 Nov; 66(5):546-54. PubMed ID: 17953530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors.
    Palmer GD; Stoddart MJ; Gouze E; Gouze JN; Ghivizzani SC; Porter RM; Evans CH
    Gene Ther; 2008 Mar; 15(5):357-63. PubMed ID: 18283289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
    Fushimi T; O'Connor TP; Crystal RG
    Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting of products of genes to tumor sites using adoptively transferred A-NK and T-LAK cells.
    Goding S; Yang Q; Mi Z; Robbins PD; Basse PH
    Cancer Gene Ther; 2007 May; 14(5):441-50. PubMed ID: 17273184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
    Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS.
    Regardsoe EL; McMenamin MM; Charlton HM; Wood MJ
    Gene Ther; 2004 Oct; 11(19):1462-74. PubMed ID: 15306838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.